Viewing nowCombinationTelobatin Tablet 40/5 mg
Telmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.

MFDS item code 202101317 · Approved 2021.02.16 · Insurance code 698004380
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of the progression of atherosclerosis
This medication is used for patients who need to take telmisartan and rosuvastatin at the same time. Telmisartan helps treat essential hypertension and reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction, stroke, and cardiovascular disease death in high-risk patients who cannot use ACE inhibitors. Rosuvastatin is used as an adjunct treatment when hypercholesterolemia and dyslipidemia cannot be managed by diet and exercise. Additionally, it delays the progression of atherosclerosis and reduces the risk of cardiovascular diseases and stroke. Therefore, this medication is used to manage both hypertension and hyperlipidemia simultaneously to improve cardiovascular health.
In a drug interaction study of the active ingredients of this medicine, telmisartan 80mg and rosuvastatin 20mg, in the presence of rosuvastatin, the Cmax of telmisartan increased by approximately 1.35-fold and its AUC increased by approximately 1.17-fold; in the presence of telmisartan, the Cmax of rosuvastatin increased by approximately 2-fold and its AUC increased by approximately 1.18-fold. Therefore, when administering this medicine, assess the potential risk associated with the increase in rosuvastatin Cmax and monitor patients closely. This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg per day. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm, particularly to the fetus and newborn, during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used by those who are allergic to this drug or its components, by women who are pregnant or may become pregnant, or by nursing mothers. Patients with severely impaired liver or kidney function, those with muscle diseases, or those with certain genetic metabolic disorders should not take this medication. Elderly patients or those with high potassium levels, liver impairment, etc., should exercise extra caution while using this medication, and regular blood tests and monitoring of their condition are necessary. This medication may cause side effects such as myalgia or muscle weakness, liver dysfunction, hypotension, or dizziness, so if abnormal symptoms occur, immediate consultation with medical personnel is required. Interactions with other medications may occur, so if you are taking other medications, it is essential to inform your healthcare provider, especially when taking together with antihypertensives, diuretics, anticoagulants, and drugs that affect liver function. This medication may affect liver and kidney function, so regular liver function tests and kidney function tests should be conducted. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so strictly adhere to the prescribed dosage and administration. Caution should be taken as drowsiness or dizziness may occur while driving or operating machinery during treatment with this medication. The safety and efficacy of this medication have not been established in children, so it is not recommended for them. This medication contains yellow dye, so individuals allergic to the dye should handle it with care. Store this medication in a place out of reach of children and do not transfer it to another container.
Increased ALT, Increased AST, Increased serum creatine phosphokinase (CPK), Dizziness, Itching, Dyspepsia, Oral paresthesia, Musculoskeletal stiffness, Acne, Nasopharyngitis, Increased serum potassium, Glycosuria, Dysuria, Rhinitis, Oral discomfort, Pulmonary disease, Gastrointestinal disease unspecified, Benign gastrointestinal neoplasm, Hemorrhoids, Skeletal pain, Osteoporosis, Sensory loss, Movement disorders, Atherosclerosis, Frequent urination, Tinnitus, Hearing loss, Halitosis, Fatty liver, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Respiratory distress, Abdominal pain, Diarrhea, Abdominal bloating, Vomiting, Abdominal discomfort, Xerostomia, Liver dysfunction, Liver impairment, Increased sweating, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Urticaria, Myalgia, Back pain, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute renal failure, Chest pain, Weakness, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Increased liver enzymes, Elevated CK, Decreased hemoglobin, Hypoglycemia, Angioedema, Diabetes, Headache, Constipation, Nausea, Pancreatitis, Itching, Rash, Urticaria, Myalgia, Myopathy, Rhabdomyolysis, Weakness, Polyneuropathy, Amnesia, Peripheral neuropathy, Cough, Respiratory distress, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Transaminase elevation, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms syndrome, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Headache, Facial spasms, Paresthesia, Paralysis, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Anorexia, Arrhythmia, Weakness, Edema, Decreased libido, Facial edema, Alopecia, Conjunctivitis, Tinnitus, Petechiae, Headache, Dizziness, Cough, Palpitations, Fatigue, Nausea, Ineffectiveness, Myalgia, Arthralgia, Increased CK, Constipation, Increased AST, Weakness, Fatigue, Numbness, Paresthesia, Chest discomfort, Nausea, Abdominal pain, Diarrhea, Anorexia, Abdominal bloating, Itching, Abnormal liver function tests, Syncope, Generalized pain, Muscle cramps, Gout, Erectile dysfunction, Acute renal failure, Oliguria, Thrombocytopenia, Increased serum creatinine, Hypotension, Tachycardia, Bradycardia, Shock, Syncope due to hypotension, Loss of consciousness, Jaundice, Liver dysfunction, Anaphylactic-like symptoms, Interstitial pneumonia, Rhabdomyolysis, Palpitations, Fatigue, Nausea, Ineffectiveness, Headache, Facial spasms, Paresthesia, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Anorexia, Arrhythmia, Weakness, Edema, Decreased libido, Facial edema, Rash, Alopecia, Conjunctivitis, Tinnitus, Petechiae, Constipation, Nausea, Pancreatitis, Itching, Rash, Urticaria, Myalgia, Myopathy, Rhabdomyolysis, Weakness, Polyneuropathy, Amnesia, Peripheral neuropathy, Cough, Respiratory distress, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Transaminase elevation, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms syndrome, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Headache, Dizziness, Cough, Palpitations, Fatigue, Nausea, Ineffectiveness
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly closed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the drug's effectiveness and safety for a long time.
Pale yellow oval film-coated tablet
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.